• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22754 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computer tomography (CT)
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2003     Canadian Task Force on Preventive Health Care (CTFPHC) Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care
2014     HAYES, Inc. Screening for Lynch syndrome
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for obesity in young population
2009     VA Technology Assessment Program (VATAP) Screening for oral cancer
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2019     European Network for Health Technology Assessment (EUnetHTA) Screening for osteoporosis in the general population
1992     University of York Screening for osteoporosis to prevent fractures
2010     Agency for Healthcare Research and Quality (AHRQ) Screening for osteoporosis: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation
1998     University of York Screening for ovarian cancer: a systematic review
1998     NIHR Health Technology Assessment programme Screening for ovarian cancer: a systematic review
2005     Agency for Healthcare Research and Quality (AHRQ) Screening for peripheral arterial disease: recommendation statement
2008     Finnish Office for Health Care Technology Assessment (Finohta) Screening for phenylketonuria in newborn in Finland
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for postmenopausal osteoporosis
2008     Health Services Assessment Collaboration (HSAC) Screening for postnatal depression within the Well Child Tamariki Ora Framework
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for prostate cancer
1997     University of York Screening for prostate cancer (includes patient leaflet 'Information for men considering or asking for PSA tests')
1999     Norwegian Knowledge Centre for the Health Services (NOKC) Screening for prostate cancer, Norwegian review of international studies
2015     NIHR Health Technology Assessment programme Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for sexually transmitted infections: a review of guidelines
2000     NIHR Health Technology Assessment programme Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research
2001     Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2006     Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delay in preschool children
1998     NIHR Health Technology Assessment programme Screening for speech and language delay: a systematic review of the literature
2015     Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delays and disorders in children age 5 years or younger: a systematic review for the U.S. Preventive Services Task Force
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force.
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for suicide risk: a systematic evidence review for the U.S. Preventive Services Task Force
2009     Health Services Assessment Collaboration (HSAC) Screening for the early detection of acoustic neuroma in patients with asymmetric sensorineural hearing loss: a rapid literature scan of MRI and other surveillance methods
2006     NIHR Health Technology Assessment programme Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for thyroid disease
2004     Health Council of the Netherlands Gezondheidsraad (GR) Screening for type 2 diabetes
2003     Agency for Healthcare Research and Quality (AHRQ) Screening for type 2 diabetes mellitus
2003     Canadian Task Force on Preventive Health Care (CTFPHC) Screening for type 2 diabetes to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care
2013     NIHR Health Technology Assessment programme Screening for type 2 diabetes: a short report for the National Screening Committee
2007     NIHR Health Technology Assessment programme Screening for type 2 diabetes: literature review and economic modelling
2008     Agency for Healthcare Research and Quality (AHRQ) Screening for type 2 diabetes: update of 2003 systematic evidence review for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening for type 2 diabetes: update of 2003 systematic evidence review for the U.S. Preventive Services Task Force.
2006     Blue Cross Blue Shield Association (BCBS) Screening for vertebral fracture with dual x-ray absorptiometry
2011     Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in children younger than age 5 years: a systematic evidence review for the U.S. Preventive Services Task Force
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2014     Agency for Healthcare Research and Quality (AHRQ) Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2006     Quality Improvement Scotland (NHS QIS ) Screening hips of newborns in Scotland: a Health Technology Assessment scoping report
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: assessment of screening instruments - a supplemental evidence update for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: assessment of screening instruments - a supplemental evidence update for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: staged systematic review for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: staged systematic review for the United States Preventive Services Task Force
2005     NIHR Health Technology Assessment programme Screening in the first year of life for congenital heart disease: review and cost-effectiveness analysis - secondary research
2007     Medical Advisory Secretariat (MAS) Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis
2002     HAYES, Inc. Screening mammography for women at average risk for breast cancer
2005     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Screening mammography: a reassessment
2009     Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2007     Institute of Health Economics (IHE) Screening newborns for cystic fibrosis
2007     Institute of Health Economics (IHE) Screening newborns for hearing: the use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Screening of cervical intraepithelial neoplasia (CIN) - primary research
2018     European Network for Health Technology Assessment (EUnetHTA) Screening of fetal trisomies 21, 18 and 13 by non invasive prenatal testing
2004     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Screening of osteoporosis by densitometry by ultrasound versus ionising techniques by X-rays. Evaluation of clinical utility and usage status in Spain
2014     Malaysian Health Technology Assessment (MaHTAS) Screening of pregnant women aged 40 years old and above for cardiac abnormalities using electrocardiography (ECG) to prevent maternal mortality
2004     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening of the hearing of newborns - systematic review of medical efficacy and economic efficiency
2006     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening of the hearing of newborns - Update
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening on urogenital chlamydia trachomatis
1998     New Zealand Health Technology Assessment (NZHTA) Screening programmes for the detection of otitis media with effusion and conductive hearing loss in pre-school and new entrant school children: a critical appraisal of the literature
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
1997     Wessex Institute for Health Research and Development (WIHRD) Screening staff for methicillin resistant Staphylococcus aureus (MRSA)
2006     New Zealand Health Technology Assessment (NZHTA) Screening strategies for antenatal Down syndrome screening
2017     NIHR Health Technology Assessment programme Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
2001     Canadian Task Force on Preventive Health Care (CTFPHC) Screening strategies for colorectal cancer: systematic review and recommendations
2012     Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for aspiration and dysphagia
2009     Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for recent heavy alcohol use
2009     NIHR Health Technology Assessment programme Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a cerebrovascular accident or traumatic brain injury: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with dementia: diagnostic accuracy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2007     Quality Improvement Scotland (NHS QIS ) Screening tools, detoxification and vitamin supplementation for alcohol dependence
2018     NIHR Health Technology Assessment programme Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018     NIHR Health Technology Assessment programme Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2012     Agency for Healthcare Research and Quality (AHRQ) Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012     Agency for Healthcare Research and Quality (AHRQ) Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2010     HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for alcohol misuse
2010     HAYES, Inc. Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2012     HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for substance use among pregnant women
2012     HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2017     NIHR Health Technology Assessment programme Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay
1994     U. S. Congress. Office of Technology Assessment (OTA) Searching for evidence: identifying health technologies that work
2008     Health Council of the Netherlands Gezondheidsraad (GR) Searchlight on radiotherapy. A vision for 2015
2020     NIHR Health Technology Assessment programme Seasonal Influenza Vaccination Effectiveness II (SIVE II): use of a large national primary care and laboratory-linked dataset to evaluate live attenuated and trivalent inactivated influenza vaccination effectiveness
2013     Belgian Health Care Knowledge Centre (KCE) Seasonal influenza vaccination: prioritizing children or other target groups? Part II: cost-effectiveness analysis
2013     NIHR Health Services and Delivery Research programme Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study - exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine
2011     Penn Medicine Center for Evidence-based Practice (CEP) Seasonal variation in readmission rates
2016     HAYES, Inc. Sebelipase Alfa (Kanuma) for treatment of lysosomal acid lipase deficiency
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sebelipase alfa for lysosomal acid lipase deficiency
2024     National Institute for Health and Care Excellence (NICE) Sebelipase alfa for treating lysosomal acid lipase deficiency that is not Wolman disease (terminated appraisal). NICE technology appraisal guidance 961
2010     HAYES, Inc. Secca (Mederi Therapeutics Inc.) procedure for fecal incontinence
2017     NIHR Health Services and Delivery Research programme Seclusion and Psychiatric Intensive Care Evaluation Study (SPICES): combined qualitative and quantitative approaches to the uses and outcomes of coercive practices in mental health services